US Stocks
/
Inhibrx Biosciences, Inc. Share Price

Inhibrx Biosciences, Inc. Share Price

NASDAQ: INBX | Small Cap
$109.35
+$4.27 (4.06%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Inhibrx Biosciences, Inc. Stock Performance

Open
$106.09
Prev. Close
$105.08
Circuit Range
N/A
Day Range
$105.23 - $109.90
Year Range
$26.54 - $153.68
Volume
9,899
Average Traded
$107.86

Inhibrx Biosciences, Inc. Share Price Today

As of 19 September 2026, Inhibrx Biosciences, Inc.'s share price is $109.35. The stock opened at $106.09, compared to its previous close of $105.08. During today's trading session, Inhibrx Biosciences, Inc.'s share price traded between $105.23 and $109.90, with an average price of $107.56. Over the past 52 weeks, the stock has recorded a high of $153.68 and a low of $26.54. In terms of performance, Inhibrx Biosciences, Inc.'s share price has risen by 62.80% over the last six months and is up 227.79% on a year-on-year basis.

Inhibrx Biosciences, Inc. Share Price Chart

$105.23$109.90
L
Show Current Price
H

Inhibrx Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.69B
PE Ratio (TTM)
-12.10
Dividend Yield
N/A
EPS (TTM)
$-9.04
Revenue (TTM)
$1.30M
Return On Equity (TTM)
-1752.22%
Profit Margin
-10773.46%
Debt to Equity
4.23
Quarterly Earnings Growth YoY
19.62%

Inhibrx Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$100000.00$0.00N/A$1.30M$0.00
Net Profit$1.86B-$43.86M-$43.31M-$28.65M-$35.26M
Net Profit Margin1858011.00%N/AN/A-2204.15%N/A
Income ChangeN/A-102.36%1.26%33.84%-23.04%

Inhibrx Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$200000.00$1.30M
Net Profit$1.69B-$140.06M
Net Profit Margin843786.00%-10773.46%
Income ChangeN/A-108.30%

About Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.

Inhibrx Biosciences, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$121.89
$109.90
-11.71%
Aug 2026
$81.20
$124.47
+51.57%
Jul 2026
$94.00
$82.12
-13.19%
Jun 2026
$102.67
$94.60
-8.87%
May 2026
$129.22
$103.81
-19.00%
Apr 2026
$68.46
$128.16
+90.80%
Mar 2026
$72.00
$67.17
-9.46%
Feb 2026
$76.28
$74.19
-3.04%
Jan 2026
$81.85
$76.52
-3.16%
Dec 2025
$82.28
$79.02
-6.40%
Nov 2025
$78.54
$84.42
+3.89%
Oct 2025
$34.08
$81.26
+143.59%

INBX Share Price FAQs

What is Inhibrx Biosciences, Inc. share price today?

chevron-up
Inhibrx Biosciences, Inc. share price today is $109.35 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Inhibrx Biosciences, Inc. stock?

chevron-up
The 52 week high of Inhibrx Biosciences, Inc. stock is $153.68, while the 52 week low is $26.54 as of 19 Sep '26.

What is INBX's market capitalisation today?

chevron-up
INBX market capitalisation is $1.69B as of September 19, 2026, at 5:40 pm IST.

What is INBX's net income for the last quarter?

chevron-up
INBX's net income for the last quarter is -0.04B USD.

What is the 5 year returns of INBX?

chevron-up
The 5 year returns of INBX is 572.92% as on 19 Sep '26.

What is the high & low stock price of INBX today?

chevron-up
INBX stock price hit a high of $109.90 and low of $105.23 as of 19 Sep '26.

Can I buy INBX shares in India?

chevron-up
Yes. You can buy INBX in India by opening an international trading account.